An overview of the combined results of tumor growth inhibition, 111In-mAb tumor uptake, 89Zr-mAb tumor uptake and target expression as determined by immunohistochemistry and FACS is presented in Table 1 for TENB2 and in Table 2 for STEAP1. This evidence concerns the gene STEAP1 and neoplasm.